First American Bank’s Biogen BIIB Stock Holding History

First American Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,692	Closed	-$2.06M	–	310
2019 Q1	$2.06M	Buy	8,692 +651	+8%	+$205K	0.15%	152
2018 Q4	$2.42M	Buy	8,041 +1,302	+19%	+$416K	0.19%	127
2018 Q3	$2.38M	Buy	+6,739	New	+$2.32M	0.16%	133
2015 Q3	–	Sell	-25,281	Closed	-$10.2M	–	242
2015 Q2	$10.2M	Buy	25,281 +24,251	+2,354%	+$9.73M	1.01%	31
2015 Q1	$435K	Hold	1,030	–	–	0.04%	145
2014 Q4	$350K	Sell	1,030 -75	-7%	-$24.3K	0.04%	146
2014 Q3	$366K	Hold	1,105	–	–	0.04%	140
2014 Q2	$348K	Hold	1,105	–	–	0.04%	146
2014 Q1	$338K	Buy	+1,105	New	+$351K	0.04%	144

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First American Bank's BIIB Position: Q2 2019 in Review

First American Bank sold out of Biogen (BIIB) in Q2 2019, closing a stake of 8,692 shares — an estimated $2.06M sold.

First American Bank first reported a position in BIIB in Q1 2014 and held it in 9 quarters. The position peaked at $10.2M in Q2 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

First American Bank reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
First American Bank sold 8,692 Biogen shares in Q2 2019, an estimated $2.06M.
First American Bank first reported a position in Biogen in Q1 2014 and held it in 9 quarters.
First American Bank's Biogen position peaked at $10.2M in Q2 2015.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on First American Bank's 13F filing for Q2 2019, filed 19 Jul 2019.